Palvella Therapeutics, Inc. (PVLA) Operating cash flow 2016–2025
Palvella Therapeutics, Inc. (PVLA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$25.0MFY2025 · since FY2016: -$14.4M → -$25.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$25.0M | -130.7% |
| FY2024 | -$10.8M | +20.9% |
| FY2023 | -$13.7M | +77.1% |
| FY2022 | -$59.9M | -682.4% |
| FY2021 | -$7.7M | +83.3% |
| FY2020 | -$45.9M | +12.5% |
| FY2019 | -$52.5M | -4821.9% |
| FY2018 | -$1.1M | -102.1% |
| FY2017 | $49.8M | +445.8% |
| FY2016 | -$14.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PVLA financial trends
PVLA RevenuePVLA Net incomePVLA Net marginPVLA Gross profitPVLA Gross marginPVLA Operating incomePVLA Operating marginPVLA Free cash flowPVLA Capital expendituresPVLA Return on equityPVLA Stock buybacksPVLA Dividends paidPVLA Total assetsPVLA Total liabilitiesPVLA Shareholders’ equityPVLA overview →